» Articles » PMID: 30606722

Burden and Impact of Multifactorial Geriatric Syndromes in Allogeneic Hematopoietic Cell Transplantation for Older Adults

Abstract

Multifactorial geriatric syndromes are highly prevalent in older patients with cancer. Because an increasing number of older patients undergo allogeneic hematopoietic stem cell transplantation (allo-HCT), we examined the incidence and impact of transplant-related geriatric syndromes using our institutional database and electronic medical records. We identified 527 patients age 60 years or older who had undergone first allo-HCT from 2001 to 2016 for hematologic malignancies. From the initiation of conditioning to 100 days posttransplant, new geriatric syndromes were predominantly delirium with a cumulative incidence of 21% (95% confidence interval [CI], 18%-25%) at day 100 followed by fall at 7% (95% CI, 5%-9%). In multivariable analyses of available pretransplant variables, fall within the last year, potentially inappropriate use of medication, thrombocytopenia, and reduced creatinine clearance were significantly associated with delirium; age older than 70 years and impaired activities of daily living were significantly associated with fall. In the 100-day landmark analysis, both delirium (hazard ratio [HR], 1.66; 95% CI, 1.09-2.52; = .023) and fall (HR, 2.14; 95% CI, 1.16-3.95; = .026) were significantly associated with increased nonrelapse mortality; moreover, fall (HR, 1.93; 95% CI, 1.18-3.14; = .016), but not delirium, was significantly associated with reduced overall survival. Here, we establish baseline incidences and risk factors of common transplant-related geriatric syndromes. Importantly, we demonstrate significant associations of delirium and fall with inferior transplant outcomes. The burden and impact of transplant-related geriatric syndromes warrant the institution of patient-centered, preemptive, longitudinal, and multidisciplinary interventions to improve outcomes for older allo-HCT patients.

Citing Articles

Association of potentially inappropriate medications with prognosis among older patients with non-small cell lung cancer.

Ma Z, Xu M, Fu M, Huang T, Shi L, Zhang Y BMC Geriatr. 2024; 24(1):550.

PMID: 38918727 PMC: 11197362. DOI: 10.1186/s12877-024-05138-3.


Transplantation and Cellular Therapy for Older Adults-The MSK Approach.

Lin R, Dahi P, Korc-Grodzicki B, Shahrokni A, Jakubowski A, Giralt S Curr Hematol Malig Rep. 2024; 19(2):82-91.

PMID: 38332462 PMC: 11126330. DOI: 10.1007/s11899-024-00725-y.


How old is too old? Frailty and geriatric assessments of older patients undergoing allogeneic HCT.

Jayani R Hematology Am Soc Hematol Educ Program. 2023; 2023(1):709-714.

PMID: 38066893 PMC: 10727072. DOI: 10.1182/hematology.2023000457.


Impact of anti-thymocyte globulin on survival outcomes in female-to-male allogeneic hematopoietic stem cell transplantation.

Tamaki M, Akahoshi Y, Ashizawa M, Misaki Y, Koi S, Kim S Sci Rep. 2023; 13(1):7166.

PMID: 37138004 PMC: 10156723. DOI: 10.1038/s41598-023-34442-y.


Potentially inappropriate medications in geriatric blood or marrow transplantation (BMT) survivors: A BMT Survivor Study report.

Sanchez-Luege S, Landier W, Dai C, Hageman L, Ross E, Balas N Cancer. 2022; 129(3):473-482.

PMID: 36413424 PMC: 10898428. DOI: 10.1002/cncr.34554.


References
1.
Fann J, Alfano C, Burington B, Roth-Roemer S, Katon W, Syrjala K . Clinical presentation of delirium in patients undergoing hematopoietic stem cell transplantation. Cancer. 2005; 103(4):810-20. DOI: 10.1002/cncr.20845. View

2.
Adeola M, Azad R, Kassie G, Shirkey B, Taffet G, Liebl M . Multicomponent Interventions Reduce High-Risk Medications for Delirium in Hospitalized Older Adults. J Am Geriatr Soc. 2018; 66(8):1638-1645. DOI: 10.1111/jgs.15438. View

3.
Marcantonio E . Delirium in Hospitalized Older Adults. N Engl J Med. 2017; 377(15):1456-1466. PMC: 5706782. DOI: 10.1056/NEJMcp1605501. View

4.
Ahmed S, Leurent B, Sampson E . Risk factors for incident delirium among older people in acute hospital medical units: a systematic review and meta-analysis. Age Ageing. 2014; 43(3):326-33. PMC: 4001175. DOI: 10.1093/ageing/afu022. View

5.
Pulte D, Jansen L, Castro F, Brenner H . Changes in the survival of older patients with hematologic malignancies in the early 21st century. Cancer. 2016; 122(13):2031-40. DOI: 10.1002/cncr.30003. View